Delivery Order SPE2DB20D7059-SPE2DB25FQNN2
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count) with a ceiling value of $1,914.97. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The order is set to be completed by July 31, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,286.99 to AmerisourceBergen Drug Corp for 120 tablets of Mesalamine DR 1.2 GM on August 15, 2025, with completion targeted for August 18, 2025. This firm fixed price delivery order represents a non-set-aside award issued under competitive procurement procedures. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120 count) on July 31, 2025, with a ceiling value of $1,422.22 and an ultimate completion date of August 1, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical procurement needs. The place of performance is located in...
- The Defense Logistics Agency (DLA) awarded a $1,694.97 delivery order to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count unit) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract was issued without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency for Mesalamine DR 1.2 GM tablets (120-count bottles) with a ceiling value of $4,353.25. The contract employs firm fixed-price pricing and is scheduled for completion by July 29, 2025. This award was competitively procured without a set-aside designation, demonstrating AmerisourceBergen's ability to compete in open federal pharmaceutical procurement. The...
- The Defense Logistics Agency awarded a delivery order valued at $8,794.31 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) under a firm fixed-price contract. This non-set-aside award was executed on August 10, 2025, with an ultimate completion date of August 11, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order represents...
- The Defense Logistics Agency awarded a delivery order valued at $12,789.51 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units). This firm fixed-price delivery order, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mesalamine DR 1.2 GM tablets (120 count) with a ceiling value of $1,320.87. This is a firm fixed price delivery order with no set-aside designation, executed through competitive procurement. The order is scheduled for ultimate completion on July 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,334.85 to AmerisourceBergen Drug Corp for the supply of Mesalamine DR 1.2 GM tablets (120-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Mesalamine DR 400 mg capsules (180-count units) with a ceiling value of $1,952.10. The contract carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be executed from the vendor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQNN2Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order on August 16, 2025, by the Defense Logistics Agency for the supply of Mesalamine DR 1.2 GM tablets (120-count units) with a ceiling value of $1,288.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999.99 million ceiling value through December 2026. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement, particularly supporting military and veteran healthcare systems. As a major pharmaceutical distributor headquartered in Pennsylvania, AmerisourceBergen serves as a prime vendor for the Defense Logistics Agency's comprehensive global pharmaceutical support program, enabling the delivery of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The firm fixed-price delivery order structure and expedited completion timeline reflect the Defense Logistics Agency's operational requirements for medical supply chain support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/16/25 |